ENHERTU
ENHERTU
Approved
DIN Number
02514400
Drug Class
Human
Market Date
Jul 9, 2021
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02514400
AIG Number0162807001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FD04 TRASTUZUMAB DERUXTECAN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TRASTUZUMAB DERUXTECANActive
Strength: 100 MG / VIAL
Monograph: TRASTUZUMAB DERUXTECAN